Tabla de Contenidos:
  • Front Cover; Drug Therapy During Pregnancy; Copyright Page; Preface; Contributors; Table of Contents; Chapter 1. Prospective study of the use of medication during pregnancy in the Netherlands; INTRODUCTION; MATERIAL AND METHODS; RESULTS; DISCUSSION; CONCLUSION; Acknowledgements; References; Chapter 2. Pharmacotherapy during pregnancy: emphasis on pharmacokinetics; INTRODUCTION; THE INFLUENCE OF PHYSIOLOGICAL CHANGES IN PREGNANCY ON PHARMACOKINETIC PARAMETERS; KINETIC CONSIDERATIONS FOR DOSAGE ADJUSTMENT IN PREGNANCY; ASPECTS OF FETAL DRUG EXPOSURE; CONCLUSION; References.
  • Chapter 3. Drugs and environmental agents in the pathogenesis of congenital malformationsENVIRONMENTAL AGENTS; CONCLUSION; Acknowledgements; References; Chapter 4. Hypertension and pregnancy; INTRODUCTION; NORMAL AND ABNORMAL BLOOD PRESSURE DURING PREGNANCY; TYPES OF HYPERTENSIVE DISORDERS; CARDIOVASCULAR DYNAMICS OF HYPERTENSION DURING PREGNANCY; PHARMACOLOGIC TREATMENT OF HYPERTENSION DURING PREGNANCY; EFFECT OF ANTIHYPERTENSIVE THERAPY ON THE MATERNAL PROGNOSIS; EFFECT OF ANTIHYPERTENSIVE TREATMENT ON UTERINE BLOOD FLOW; EFFECT OF ANTIHYPERTENSIVE THERAPY ON THE FETUS AND NEONATE.
  • RECOMMENDATIONS FOR CURRENT TREATMENTReferences; Chapter 5. Non-steroidal anti-inflammatory agents; PHARMACOLOGY; PLACENTAL TRANSFER AND KINETICS; ADMINISTRATION AND INGESTION DURING PREGNANCY; GENERAL FETAL EFFECTS; FETAL EFFECTS THROUGH INHIBITION OF PHYSIOLOGIC FUNCTION; CONCLUSION; Acknowledgements; References; Chapter 6. Antiepileptics; DIPHENYLHYDANTOIN; VALPROIC ACID; DIAZEPAM; CARBAMAZEPINE; BARBITURATES; MAGNESIUM SULFATE; TERATOGENICITY; CONCLUSION; References; Chapter 7. Hormonal therapy during pregnancy; THYROID AND ANTITHYROID DRUGS; SEX HORMONES; Summary; CORTICOSTEROIDS.
  • INSULINReferences; Chapter 8. Anesthesia during pregnancy and parturition; PERINATAL PHARMACOLOGY; SURGICAL ANESTHESIA DURING PREGNANCY; PRACTICAL CONSIDERATIONS; References; Chapter 9. Stimulation of uterine activity; INTRODUCTION; OXYTOCIN; PROSTAGLANDINS; CONCLUSION; Acknowledgement; References; Chapter 10. The use of beta-adrenergic drugs in obstetrics; INTRODUCTION; CLINICAL APPLICATION OF BETA-ADRENERGIC DRUGS IN PRETERM LABOR; MATERNAL EFFECTS; FETAL EFFECTS; NEONATAL EFFECTS; CONCLUSION; References; Chapter 11. Drugs and fetal heart rate patterns; INTRODUCTION.
  • DRUGS THAT REDUCE FETAL HEART RATE VARIABILITYDRUGS THAT ENHANCE FETAL HEART RATE VARIABILITY; COMMENTS; References; Chapter 12. Reproductive and developmentaltoxicology; INTRODUCTION; REPRODUCTIVE TOXICITY IN THE FEMALE; PREIMPLANTATION TOXICITY; PLACENTAL TOXICITY; FETAL TOXICITY/TRANSPLACENTAL CARCINOGENICITY; CONCLUSIONS; Acknowledgements; References; Index.